Careers  |  Sign In  |  Register  |   Twitter

Suspension of Proteinase Inhibitor

Increased risk of death with Trasylol

The FDA announced that Trasylol increases risk of death, and therefore a marketing suspension has occurred.

References and Resources
FDA Requests Marketing Suspension of Trasylol

Click Here to read the update.

Sponsored by Thr Doctor’s Channel